The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources
Author
DiStefano, M. T.
Goehringer, S.
Babb, L.
Alkuraya, F. S.
Amberger, J.
Amin, M.
Austin-Tse, C.
Balzotti, M.
Berg, J. S.
Birney, E.
Bocchini, C.
Bruford, E. A.
Coffey, A. J.
Collins, H.
Cunningham, F.
Daugherty, L. C.
Einhorn, Y.
Firth, H. V.
Fitzpatrick, D. R.
Foulger, R. E.
Goldstein, J.
Hamosh, A.
Hurles, M. R.
Leigh, S. E.
Leong, I. U. S.
Maddirevula, S.
Martin, C. L.
McDonagh, E. M.
Olry, A.
Puzriakova, A.
Radtke, K.
Ramos, E. M.
Rath, A.
Riggs, E. R.
Roberts, A. M.
Rodwell, C.
Snow, C.
Stark, Z.
Tahiliani, J.
Tweedie, S.
Ware, J. S.
Weller, P.
Williams, E.
Wright, C. F.
Yates, T. M.
Rehm, H. L.
Date
2022-08-01Journal
Genetics in medicineType
Journal ArticlePublisher
NatureDOI
10.1016/j.gim.2022.04.017Rights
Copyright © 2022 American College of Medical Genetics and Genomics. All rights reserved.Metadata
Show full item recordAbstract
PURPOSE: Several groups and resources provide information that pertains to the validity of gene-disease relationships used in genomic medicine and research; however, universal standards and terminologies to define the evidence base for the role of a gene in disease and a single harmonized resource were lacking. To tackle this issue, the Gene Curation Coalition (GenCC) was formed. METHODS: The GenCC drafted harmonized definitions for differing levels of gene-disease validity on the basis of existing resources, and performed a modified Delphi survey with 3 rounds to narrow the list of terms. The GenCC also developed a unified database to display curated gene-disease validity assertions from its members. RESULTS: On the basis of 241 survey responses from the genetics community, a consensus term set was chosen for grading gene-disease validity and database submissions. As of December 2021, the database contained 15,241 gene-disease assertions on 4569 unique genes from 12 submitters. When comparing submissions to the database from distinct sources, conflicts in assertions of gene-disease validity ranged from 5.3% to 13.4%. CONCLUSION: Terminology standardization, sharing of gene-disease validity classifications, and resolution of curation conflicts will facilitate collaborations across international curation efforts and in turn, improve consistency in genetic testing and variant interpretation.